Streptococcus agalactiae Lehmann and Neumann (ATCC® BAA-22)

Strain Designations: M781  /  Type Strain: no  /  Biosafety Level: 2

Strain Designations M781
Application
Produces capsular polysaccharide type III
Isolation
Cerebrospinal fluid of an infant with neonatal meningitis, 1978
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Antigenic Properties Serotype III
Product Format freeze-dried
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Preceptrol® no
Type Strain no
Antigenic Properties Serotype III
Name of Depositor CJ Baker
Special Collection NCRR Contract
Isolation
Cerebrospinal fluid of an infant with neonatal meningitis, 1978
Year of Origin 1978
References

Anderson DC, et al. Impaired chemotaxigenesis by type III group B streptococci in neonatal sera: relationship to diminished concentration of specific anticapsular antibody and abnormalities of serum complement. Pediatr. Res. 17: 496-502, 1983. PubMed: 6348689

Kasper DL, et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J. Clin. Invest. 98: 2308-2314, 1996. PubMed: 8941648

BD MAX™ GBS Assay. BD Becton Dickinson.